Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.

Loebbermann J, Thornton H, Durant L, Sparwasser T, Webster KE, Sprent J, Culley FJ, Johansson C, Openshaw PJ.

Mucosal Immunol. 2012 Mar;5(2):161-72. doi: 10.1038/mi.2011.62.

2.

Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.

Fulton RB, Meyerholz DK, Varga SM.

J Immunol. 2010 Aug 15;185(4):2382-92. doi: 10.4049/jimmunol.1000423.

3.
4.

Granzyme B regulates antiviral CD8+ T cell responses.

Salti SM, Hammelev EM, Grewal JL, Reddy ST, Zemple SJ, Grossman WJ, Grayson MH, Verbsky JW.

J Immunol. 2011 Dec 15;187(12):6301-9. doi: 10.4049/jimmunol.1100891.

5.

The role of Th17 and Treg responses in the pathogenesis of RSV infection.

Mangodt TC, Van Herck MA, Nullens S, Ramet J, De Dooy JJ, Jorens PG, De Winter BY.

Pediatr Res. 2015 Nov;78(5):483-91. doi: 10.1038/pr.2015.143. Review.

PMID:
26267154
6.

Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.

Hwang HS, Kwon YM, Lee JS, Yoo SE, Lee YN, Ko EJ, Kim MC, Cho MK, Lee YT, Jung YJ, Lee JY, Li JD, Kang SM.

Antiviral Res. 2014 Oct;110:115-23. doi: 10.1016/j.antiviral.2014.07.016.

7.

Respiratory syncytial virus infection is associated with an altered innate immunity and a heightened pro-inflammatory response in the lungs of preterm lambs.

Sow FB, Gallup JM, Krishnan S, Patera AC, Suzich J, Ackermann MR.

Respir Res. 2011 Aug 9;12:106. doi: 10.1186/1465-9921-12-106.

8.

Pulmonary V gamma 4+ gamma delta T cells have proinflammatory and antiviral effects in viral lung disease.

Dodd J, Riffault S, Kodituwakku JS, Hayday AC, Openshaw PJ.

J Immunol. 2009 Jan 15;182(2):1174-81.

9.

Galectin-9 ameliorates respiratory syncytial virus-induced pulmonary immunopathology through regulating the balance between Th17 and regulatory T cells.

Lu X, McCoy KS, Xu J, Hu W, Chen H, Jiang K, Han F, Chen P, Wang Y.

Virus Res. 2015 Jan 2;195:162-71. doi: 10.1016/j.virusres.2014.10.011.

PMID:
25451068
10.

Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection.

Shao HY, Huang JY, Lin YW, Yu SL, Chitra E, Chang CK, Sung WC, Chong P, Chow YH.

Int J Infect Dis. 2015 Dec;41:56-64. doi: 10.1016/j.ijid.2015.10.026.

11.

Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.

Christiaansen AF, Boggiatto PM, Varga SM.

J Immunol Methods. 2014 Apr;406:58-65. doi: 10.1016/j.jim.2014.03.005.

12.

IL-12p40 and IL-18 modulate inflammatory and immune responses to respiratory syncytial virus infection.

Wang SZ, Bao YX, Rosenberger CL, Tesfaigzi Y, Stark JM, Harrod KS.

J Immunol. 2004 Sep 15;173(6):4040-9.

13.

IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.

Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, Lukacs NW.

Am J Pathol. 2011 Jul;179(1):248-58. doi: 10.1016/j.ajpath.2011.03.003.

15.

Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells.

Loebbermann J, Durant L, Thornton H, Johansson C, Openshaw PJ.

Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2987-92. doi: 10.1073/pnas.1217580110.

16.
17.

Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.

Moore ML, Chi MH, Goleniewska K, Durbin JE, Peebles RS Jr.

Viral Immunol. 2008 Sep;21(3):327-39. doi: 10.1089/vim.2008.0003.

18.

CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection.

Lee DC, Harker JA, Tregoning JS, Atabani SF, Johansson C, Schwarze J, Openshaw PJ.

J Virol. 2010 Sep;84(17):8790-8. doi: 10.1128/JVI.00796-10.

19.

Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge.

Tasker L, Lindsay RW, Clarke BT, Cochrane DW, Hou S.

Clin Exp Immunol. 2008 Aug;153(2):277-88. doi: 10.1111/j.1365-2249.2008.03591.x.

20.

The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.

Stokes KL, Currier MG, Sakamoto K, Lee S, Collins PL, Plemper RK, Moore ML.

J Virol. 2013 Sep;87(18):10070-82. doi: 10.1128/JVI.01347-13.

Items per page

Supplemental Content

Support Center